Sklerosierungstherapie von retikulären und Besenreiservarizen

Dieser Artikel behandelt die leitliniengerechte Indikationsstellung, Behandlungsabläufe, Behandlungsmöglichkeiten sowie die Vermeidung von Komplikationen bei der Sklerosierungstherapie von retikulären und Besenreiservarizen in der phlebologischen Praxis.

Abstract

This article discusses the guideline-based indications, treatment options and procedures as well as avoidance of complication in sclerotherapy of reticular and spider varicose veins in daily practice.

Schlüsselwörter

retikuläre Varizen - Besenreiser - Besenreiservarizen - Sklerotherapie - Schaumsklerosierung - Flüssigsklerosierung

Keywords

varicose veins - reticular varicosis - spider veins - sclerotherapy - foam sclerotherapy - liquid sclerotherapy

Publication History

Article published online:
14 February 2024

• Literatur

• 1 Rabe E, Pannier-Fischer F, Bromen K. et al. Bonner Venenstudie der Deutschen Gesellschaft für Phlebologie. Phlebologie 2003; 32
• 2 Lurie F, Passman M, Meisner M. et al. The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord 2020; 8
• 3 Marsden G, Perry M, Kelley K. et al. Diagnosis and management of varicose veins in the legs: Summary of NICE guidance. BMJ (Online) 2013; 347
• 4 Rabe E, Breu FX, Flessenkämper I. et al. Leitlinie Sklerosierungsbehandlung der Varikose. Der Hautarzt 2021; 72: 50-64
• 5 De Maeseneer MG, Kakkos SK, Aherne T. et al. Editor’s Choice – European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. European Journal of Vascular and Endovascular Surgery 2022; 63
• 6 Waldhausen P. Verödungstherapie, Geschichte und Entwicklung der Verödungstherapie. In: Varikose: Diagnostik-Therapie-Begutachtung. Springer-Verlag; 2010: 267 ff
• 7 Kreussler: Fachinformationen Aethoxysklerol ® 0,25% / 0,5% / 1% / 2% /3% Stand August 2015, Chemische Fabrik Kreussler & Co GmbH.
• 8 Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatologic Surgery 2001; 27
• 9 Rathbun S, Norris A, Stoner J. Efficacy and safety of endovenous foam sclerotherapy: meta-analysis for treatment of venous disorders. Phlebology 2012; 27: 105-117
• 10 Hach W. Sklerosierung. In: VenenChirurgie: operative, interventionelle und konservative Aspekte. Schattauer; 2013: 43-50
• 11 Deutsche Gesellschaft für Angiologie. S2k-Leitlinie „Diagnostik und Therapie der Venenthrombose und der Lungenembolie. 2023 https://register.awmf.org/de/leitlinien/detail/065–002 2023
• 12 Rabe E, Breu FX, Cavezzi A. et al. European guidelines for sclerotherapy in chronic venous disorders. Phlebology 2014; 29
• 13 Prophylaxe der venösen Thromboembolie (VTE). Vasa 2016; 45: 1-88
• 14 Rabe E, Pannier F. Indications, contraindications and performance: European Guidelines for Sclerotherapy in Chronic Venous Disorders*. Phlebology 2014; 29
• 15 Bihari I, Magyar É. Reasons for ulceration after injection treatment of telangiectasia. Dermatologic Surgery 2001; 27
• 16 Parsi K. Paradoxical embolism, stroke and sclerotherapy. Phlebology 2012; 27
• 17 Zouitina Y, Terrier M, Hyra M. et al. Prolonged acute migraine with aura and reversible brain MRI abnormalities after liquid sclerotherapy. Journal of Headache and Pain 2014; 15
• 18 Goldman MP, Sadick NS, Weiss RA. Cutaneous Necrosis, Telangiectatic Matting, and Hyperpigmentation following Sclerotherapy Etiology, Prevention, and Treatment. Dermatologic Surgery 1995; 21
• 19 Scultetus AH, Villavicencio JL, Kao TC. et al. Microthrombectomy reduces postsclerotherapy pigmentation: Multicenter randomized trial. Journal of Vascular Surgery 2003; 38 (05) 896-903
• 20 Miyake RK, Ramacciotti E. Cryo-laser and cryo-sclerotherapy guided by augmented reality for telangiectasias, feeder, and small varicose vein treatment–The CLaCS technique white paper report.